Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 273 No 7330 p888
18/25 December 2004


Society summary


Improved process for responding to BRM resolutions

The Council is taking steps to improve the process for producing its responses to resolutions of the branch representatives’ meeting.

The December Council meeting agreed that a template should be produced to help committees and directorates to frame draft responses. The template will be designed to ensure that, when the Council decides not to act in accordance with a BRM resolution, the response will fully explain why the Council cannot take the requested course of action, even if it is sympathetic with the resolution. Such reasons may be that the action called for is outside the Society’s remit or powers, is contrary to the policy position adopted by the Council, may require resources that are not available or are allocated to other priorities.

It was also agreed that committees should be asked to reserve time where appropriate for full discussion of resolutions.

It was further agreed that the President should make a presentation at the BRM to reinforce information already supplied to the branches and that progress reports should be placed on the Society’s website.

Finally, the Council agreed that the branches should be consulted again on how the BRM might develop in order to maximise its contribution and impact.

During the Council’s debate, Christine Glover said that the opportunity to use the BRM for better end had to be made explicit. It was a perfect way to get members involved with policy development. Participants would feel better if they felt the BRM contributed and improved Council’s views about what the members think about policies that need to be moved forward.

Clive Jackson said that the Council should consult not only the branches but also the wider membership. “What we really want are branch representative meetings that are what the membership wants as a whole,” he suggested.

Back to Top


©The Pharmaceutical Journal